How I treat immune-mediated thrombotic thrombocytopenic purpura after hospital discharge.

Akwaa, Frank; Antun, Ana; Cataland, Spero R

Akwaa, Frank; Antun, Ana; Cataland, Spero R.

Affiliation

Akwaa F; Division of Hematology and Oncology, Department of Medicine, University of Rochester, Rochester, NY.
Antun A; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA; and.
Cataland SR; Department of Medicine, The Ohio State University, Columbus, OH.

Blood ; 140(5): 438-444, 2022 08 04.

Article in En | MEDLINE | ID: mdl-35667044

Subject(s)

Purpura, Thrombocytopenic, Idiopathic; Purpura, Thrombotic Thrombocytopenic; ADAMTS13 Protein; Hospitals; Humans; Patient Discharge; Plasma Exchange; Purpura, Thrombocytopenic, Idiopathic/therapy; Recurrence

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Purpura, Thrombotic Thrombocytopenic / Purpura, Thrombocytopenic, Idiopathic Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Blood Year: 2022 Type: Article

Fulltext

XML

PubMed Links

Search on Google